Equity Research, Broker Reports, and media content on Sanofi

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Sanofi
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Sanofi. We currently have 15 research reports from 1 professional analysts.

Open
6370c
Volume
1.7m
Range Today
6360/6490c
52 Week
6310/9300c
Market Cap
81,283m
Enterprise Value
n/am
Pension Liability
# Shares
0m
Latest PE (hist)
Div Yield
Date Source Announcement
21May18 19:15 GNW Sanofi: New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma
16May18 06:00 GNW Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
14May18 07:09 GNW Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14May18 07:00 GNW Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
02May18 17:50 GNW Sanofi: Annual General Shareholders' Meeting of May 2, 2018
30Apr18 06:01 GNW Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
27Apr18 06:30 GNW Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER
  • Frequency of research reports

     

  • Research reports on

    Sanofi

  • Providers covering

    Sanofi